Literature DB >> 27923109

Generation of Domain-Specific Monoclonal Antibodies Against Human Glutaredoxin3.

Xin Dai1, Yanqing Li1, Xiaohong Sun1, Kai Cai1, Qinwen Mao2, Haibin Xia1.   

Abstract

Human Glutaredoxin3 (hGLRX3), which encodes a 37.4 kDa protein, possesses an N-terminal Trx homology domain followed by two tandem repeats of Grx domains. GLRX3 is expressed in many tissues and plays important roles in iron metabolism, antioxidant effect, cell proliferation and development, regulation of immune reaction, and tumorigenesis. The mechanisms underlying the biological function of GLRX3 are still not clear. To facilitate the functional research of GLRX3, in this study, monoclonal antibodies (MAbs) against hGLRX3 were produced by using purified prokaryotic recombinant 6His-hGLRX3 fusion protein as the immunogen. Five MAbs were obtained after preliminary screening by indirect enzyme-linked immunosorbent assay, then further characterized by Western blot analysis and immunocytochemistry. The domain specificity of these MAbs was also evaluated. Owing to the high conservation of protein sequences among different species, anti-GLRX3 MAbs produced in this study were shown to be immunoactive for GLRX3 in the cells from other species, such as mice, rats, Chinese hamster, and zebrafish. These domain-specific anti-GLRX3 MAbs will be an essential tool to investigate the roles of GLRX3 in normal physiological or pathological conditions.

Entities:  

Keywords:  Glutaredoxin3; hybridoma; monoclonal antibody; prokaryotic expression

Mesh:

Substances:

Year:  2016        PMID: 27923109     DOI: 10.1089/mab.2016.0032

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  1 in total

Review 1.  Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics.

Authors:  Justin Lengfeld; Hongtao Zhang; Steven Stoesz; Ramachandran Murali; Franklin Pass; Mark I Greene; Peeyush N Goel; Payal Grover
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.